aluates Reports

$ 0.0

Automative

Global Diagnostic Exosome Biomarker Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-30R5615

Global Diagnostic Exosome Biomarker Market Insights Forecast to 2028

BUY CHAPTERS

Global Diagnostic Exosome Biomarker Market Research Report 2025

Code: QYRE-Auto-30R5615

Report

June 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

101Bio

AMS Biotechnology

BioRegenerative Sciences

Cell Guidance Systems

Codiak BioSciences

Evomic Science

ExoCyte Therapeutics

Bio-Techne

Exovita biosciences

Immune Therapy Holdings

Lonza

Norgen Biotek

ReNeuron Group

Therapeutic Solutions International

Diagnostic Exosome Biomarker Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Diagnostic Exosome Biomarker Market

The global market for Diagnostic Exosome Biomarker was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The fusion of plasma membrane with the internal vesicle fusion leads to the secretion of nanovescicles called exosomes into the extracellular environment. The exosomes are released in easily accessible body fluids such as urine and blood and hence acts as a precious source of biomedical tool. As cancer is a booming research area, exosomes may act as a very useful biomarkers for the diagnosis and prognosis of malignant tumor. The application of exosome as a potential biomarker for the various neurodegenerative disorders is also under investigation.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Exosome Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Exosome Biomarker.

The Diagnostic Exosome Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Exosome Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Exosome Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Exosome Biomarker Market Report

Report Metric	Details
Report Name	Diagnostic Exosome Biomarker Market
CAGR	5%
Segment by Type	Membrane-bound Proteins Soluble Proteins Noncoding RNA Others
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	101Bio, AMS Biotechnology, BioRegenerative Sciences, Cell Guidance Systems, Codiak BioSciences, Evomic Science, ExoCyte Therapeutics, Bio-Techne, Exovita biosciences, Immune Therapy Holdings, Lonza, Norgen Biotek, ReNeuron Group, Therapeutic Solutions International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Exosome Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diagnostic Exosome Biomarker Market report?

Ans: The main players in the Diagnostic Exosome Biomarker Market are 101Bio, AMS Biotechnology, BioRegenerative Sciences, Cell Guidance Systems, Codiak BioSciences, Evomic Science, ExoCyte Therapeutics, Bio-Techne, Exovita biosciences, Immune Therapy Holdings, Lonza, Norgen Biotek, ReNeuron Group, Therapeutic Solutions International

What are the Application segmentation covered in the Diagnostic Exosome Biomarker Market report?

Ans: The Applications covered in the Diagnostic Exosome Biomarker Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Diagnostic Exosome Biomarker Market report?

Ans: The Types covered in the Diagnostic Exosome Biomarker Market report are Membrane-bound Proteins, Soluble Proteins, Noncoding RNA, Others

Recommended Reports

Exosome Diagnostics

Cancer Diagnosis

Sepsis & Precision

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diagnostic Exosome Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Membrane-bound Proteins

1.2.3 Soluble Proteins

1.2.4 Noncoding RNA

1.2.5 Others

1.3 Market by Application

1.3.1 Global Diagnostic Exosome Biomarker Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diagnostic Exosome Biomarker Market Perspective (2020-2031)

2.2 Global Diagnostic Exosome Biomarker Growth Trends by Region

2.2.1 Global Diagnostic Exosome Biomarker Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diagnostic Exosome Biomarker Historic Market Size by Region (2020-2025)

2.2.3 Diagnostic Exosome Biomarker Forecasted Market Size by Region (2026-2031)

2.3 Diagnostic Exosome Biomarker Market Dynamics

2.3.1 Diagnostic Exosome Biomarker Industry Trends

2.3.2 Diagnostic Exosome Biomarker Market Drivers

2.3.3 Diagnostic Exosome Biomarker Market Challenges

2.3.4 Diagnostic Exosome Biomarker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diagnostic Exosome Biomarker Players by Revenue

3.1.1 Global Top Diagnostic Exosome Biomarker Players by Revenue (2020-2025)

3.1.2 Global Diagnostic Exosome Biomarker Revenue Market Share by Players (2020-2025)

3.2 Global Diagnostic Exosome Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diagnostic Exosome Biomarker Revenue

3.4 Global Diagnostic Exosome Biomarker Market Concentration Ratio

3.4.1 Global Diagnostic Exosome Biomarker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Exosome Biomarker Revenue in 2024

3.5 Global Key Players of Diagnostic Exosome Biomarker Head office and Area Served

3.6 Global Key Players of Diagnostic Exosome Biomarker, Product and Application

3.7 Global Key Players of Diagnostic Exosome Biomarker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Exosome Biomarker Breakdown Data by Type

4.1 Global Diagnostic Exosome Biomarker Historic Market Size by Type (2020-2025)

4.2 Global Diagnostic Exosome Biomarker Forecasted Market Size by Type (2026-2031)

5 Diagnostic Exosome Biomarker Breakdown Data by Application

5.1 Global Diagnostic Exosome Biomarker Historic Market Size by Application (2020-2025)

5.2 Global Diagnostic Exosome Biomarker Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diagnostic Exosome Biomarker Market Size (2020-2031)

6.2 North America Diagnostic Exosome Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diagnostic Exosome Biomarker Market Size by Country (2020-2025)

6.4 North America Diagnostic Exosome Biomarker Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diagnostic Exosome Biomarker Market Size (2020-2031)

7.2 Europe Diagnostic Exosome Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diagnostic Exosome Biomarker Market Size by Country (2020-2025)

7.4 Europe Diagnostic Exosome Biomarker Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diagnostic Exosome Biomarker Market Size (2020-2031)

8.2 Asia-Pacific Diagnostic Exosome Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2020-2025)

8.4 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diagnostic Exosome Biomarker Market Size (2020-2031)

9.2 Latin America Diagnostic Exosome Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diagnostic Exosome Biomarker Market Size by Country (2020-2025)

9.4 Latin America Diagnostic Exosome Biomarker Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diagnostic Exosome Biomarker Market Size (2020-2031)

10.2 Middle East & Africa Diagnostic Exosome Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2020-2025)

10.4 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 101Bio

11.1.1 101Bio Company Details

11.1.2 101Bio Business Overview

11.1.3 101Bio Diagnostic Exosome Biomarker Introduction

11.1.4 101Bio Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.1.5 101Bio Recent Development

11.2 AMS Biotechnology

11.2.1 AMS Biotechnology Company Details

11.2.2 AMS Biotechnology Business Overview

11.2.3 AMS Biotechnology Diagnostic Exosome Biomarker Introduction

11.2.4 AMS Biotechnology Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.2.5 AMS Biotechnology Recent Development

11.3 BioRegenerative Sciences

11.3.1 BioRegenerative Sciences Company Details

11.3.2 BioRegenerative Sciences Business Overview

11.3.3 BioRegenerative Sciences Diagnostic Exosome Biomarker Introduction

11.3.4 BioRegenerative Sciences Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.3.5 BioRegenerative Sciences Recent Development

11.4 Cell Guidance Systems

11.4.1 Cell Guidance Systems Company Details

11.4.2 Cell Guidance Systems Business Overview

11.4.3 Cell Guidance Systems Diagnostic Exosome Biomarker Introduction

11.4.4 Cell Guidance Systems Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.4.5 Cell Guidance Systems Recent Development

11.5 Codiak BioSciences

11.5.1 Codiak BioSciences Company Details

11.5.2 Codiak BioSciences Business Overview

11.5.3 Codiak BioSciences Diagnostic Exosome Biomarker Introduction

11.5.4 Codiak BioSciences Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.5.5 Codiak BioSciences Recent Development

11.6 Evomic Science

11.6.1 Evomic Science Company Details

11.6.2 Evomic Science Business Overview

11.6.3 Evomic Science Diagnostic Exosome Biomarker Introduction

11.6.4 Evomic Science Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.6.5 Evomic Science Recent Development

11.7 ExoCyte Therapeutics

11.7.1 ExoCyte Therapeutics Company Details

11.7.2 ExoCyte Therapeutics Business Overview

11.7.3 ExoCyte Therapeutics Diagnostic Exosome Biomarker Introduction

11.7.4 ExoCyte Therapeutics Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.7.5 ExoCyte Therapeutics Recent Development

11.8 Bio-Techne

11.8.1 Bio-Techne Company Details

11.8.2 Bio-Techne Business Overview

11.8.3 Bio-Techne Diagnostic Exosome Biomarker Introduction

11.8.4 Bio-Techne Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.8.5 Bio-Techne Recent Development

11.9 Exovita biosciences

11.9.1 Exovita biosciences Company Details

11.9.2 Exovita biosciences Business Overview

11.9.3 Exovita biosciences Diagnostic Exosome Biomarker Introduction

11.9.4 Exovita biosciences Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.9.5 Exovita biosciences Recent Development

11.10 Immune Therapy Holdings

11.10.1 Immune Therapy Holdings Company Details

11.10.2 Immune Therapy Holdings Business Overview

11.10.3 Immune Therapy Holdings Diagnostic Exosome Biomarker Introduction

11.10.4 Immune Therapy Holdings Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.10.5 Immune Therapy Holdings Recent Development

11.11 Lonza

11.11.1 Lonza Company Details

11.11.2 Lonza Business Overview

11.11.3 Lonza Diagnostic Exosome Biomarker Introduction

11.11.4 Lonza Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.11.5 Lonza Recent Development

11.12 Norgen Biotek

11.12.1 Norgen Biotek Company Details

11.12.2 Norgen Biotek Business Overview

11.12.3 Norgen Biotek Diagnostic Exosome Biomarker Introduction

11.12.4 Norgen Biotek Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.12.5 Norgen Biotek Recent Development

11.13 ReNeuron Group

11.13.1 ReNeuron Group Company Details

11.13.2 ReNeuron Group Business Overview

11.13.3 ReNeuron Group Diagnostic Exosome Biomarker Introduction

11.13.4 ReNeuron Group Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.13.5 ReNeuron Group Recent Development

11.14 Therapeutic Solutions International

11.14.1 Therapeutic Solutions International Company Details

11.14.2 Therapeutic Solutions International Business Overview

11.14.3 Therapeutic Solutions International Diagnostic Exosome Biomarker Introduction

11.14.4 Therapeutic Solutions International Revenue in Diagnostic Exosome Biomarker Business (2020-2025)

11.14.5 Therapeutic Solutions International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

101Bio

AMS Biotechnology

BioRegenerative Sciences

Cell Guidance Systems

Codiak BioSciences

Evomic Science

ExoCyte Therapeutics

Bio-Techne

Exovita biosciences

Immune Therapy Holdings

Lonza

Norgen Biotek

ReNeuron Group

Therapeutic Solutions International

List of Tables

Table 1. Global Diagnostic Exosome Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Membrane-bound Proteins

Table 3. Key Players of Soluble Proteins

Table 4. Key Players of Noncoding RNA

Table 5. Key Players of Others

Table 6. Global Diagnostic Exosome Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Diagnostic Exosome Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Diagnostic Exosome Biomarker Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Diagnostic Exosome Biomarker Market Share by Region (2020-2025)

Table 10. Global Diagnostic Exosome Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Diagnostic Exosome Biomarker Market Share by Region (2026-2031)

Table 12. Diagnostic Exosome Biomarker Market Trends

Table 13. Diagnostic Exosome Biomarker Market Drivers

Table 14. Diagnostic Exosome Biomarker Market Challenges

Table 15. Diagnostic Exosome Biomarker Market Restraints

Table 16. Global Diagnostic Exosome Biomarker Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Diagnostic Exosome Biomarker Market Share by Players (2020-2025)

Table 18. Global Top Diagnostic Exosome Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Exosome Biomarker as of 2024)

Table 19. Ranking of Global Top Diagnostic Exosome Biomarker Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Diagnostic Exosome Biomarker Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Diagnostic Exosome Biomarker, Headquarters and Area Served

Table 22. Global Key Players of Diagnostic Exosome Biomarker, Product and Application

Table 23. Global Key Players of Diagnostic Exosome Biomarker, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Diagnostic Exosome Biomarker Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2020-2025)

Table 27. Global Diagnostic Exosome Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Diagnostic Exosome Biomarker Revenue Market Share by Type (2026-2031)

Table 29. Global Diagnostic Exosome Biomarker Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Diagnostic Exosome Biomarker Revenue Market Share by Application (2020-2025)

Table 31. Global Diagnostic Exosome Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Diagnostic Exosome Biomarker Revenue Market Share by Application (2026-2031)

Table 33. North America Diagnostic Exosome Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Diagnostic Exosome Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Diagnostic Exosome Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Diagnostic Exosome Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Diagnostic Exosome Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Diagnostic Exosome Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Diagnostic Exosome Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Diagnostic Exosome Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Diagnostic Exosome Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Diagnostic Exosome Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Diagnostic Exosome Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country (2026-2031) & (US$ Million)

Table 48. 101Bio Company Details

Table 49. 101Bio Business Overview

Table 50. 101Bio Diagnostic Exosome Biomarker Product

Table 51. 101Bio Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 52. 101Bio Recent Development

Table 53. AMS Biotechnology Company Details

Table 54. AMS Biotechnology Business Overview

Table 55. AMS Biotechnology Diagnostic Exosome Biomarker Product

Table 56. AMS Biotechnology Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 57. AMS Biotechnology Recent Development

Table 58. BioRegenerative Sciences Company Details

Table 59. BioRegenerative Sciences Business Overview

Table 60. BioRegenerative Sciences Diagnostic Exosome Biomarker Product

Table 61. BioRegenerative Sciences Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 62. BioRegenerative Sciences Recent Development

Table 63. Cell Guidance Systems Company Details

Table 64. Cell Guidance Systems Business Overview

Table 65. Cell Guidance Systems Diagnostic Exosome Biomarker Product

Table 66. Cell Guidance Systems Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 67. Cell Guidance Systems Recent Development

Table 68. Codiak BioSciences Company Details

Table 69. Codiak BioSciences Business Overview

Table 70. Codiak BioSciences Diagnostic Exosome Biomarker Product

Table 71. Codiak BioSciences Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 72. Codiak BioSciences Recent Development

Table 73. Evomic Science Company Details

Table 74. Evomic Science Business Overview

Table 75. Evomic Science Diagnostic Exosome Biomarker Product

Table 76. Evomic Science Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 77. Evomic Science Recent Development

Table 78. ExoCyte Therapeutics Company Details

Table 79. ExoCyte Therapeutics Business Overview

Table 80. ExoCyte Therapeutics Diagnostic Exosome Biomarker Product

Table 81. ExoCyte Therapeutics Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 82. ExoCyte Therapeutics Recent Development

Table 83. Bio-Techne Company Details

Table 84. Bio-Techne Business Overview

Table 85. Bio-Techne Diagnostic Exosome Biomarker Product

Table 86. Bio-Techne Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 87. Bio-Techne Recent Development

Table 88. Exovita biosciences Company Details

Table 89. Exovita biosciences Business Overview

Table 90. Exovita biosciences Diagnostic Exosome Biomarker Product

Table 91. Exovita biosciences Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 92. Exovita biosciences Recent Development

Table 93. Immune Therapy Holdings Company Details

Table 94. Immune Therapy Holdings Business Overview

Table 95. Immune Therapy Holdings Diagnostic Exosome Biomarker Product

Table 96. Immune Therapy Holdings Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 97. Immune Therapy Holdings Recent Development

Table 98. Lonza Company Details

Table 99. Lonza Business Overview

Table 100. Lonza Diagnostic Exosome Biomarker Product

Table 101. Lonza Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 102. Lonza Recent Development

Table 103. Norgen Biotek Company Details

Table 104. Norgen Biotek Business Overview

Table 105. Norgen Biotek Diagnostic Exosome Biomarker Product

Table 106. Norgen Biotek Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 107. Norgen Biotek Recent Development

Table 108. ReNeuron Group Company Details

Table 109. ReNeuron Group Business Overview

Table 110. ReNeuron Group Diagnostic Exosome Biomarker Product

Table 111. ReNeuron Group Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 112. ReNeuron Group Recent Development

Table 113. Therapeutic Solutions International Company Details

Table 114. Therapeutic Solutions International Business Overview

Table 115. Therapeutic Solutions International Diagnostic Exosome Biomarker Product

Table 116. Therapeutic Solutions International Revenue in Diagnostic Exosome Biomarker Business (2020-2025) & (US$ Million)

Table 117. Therapeutic Solutions International Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Diagnostic Exosome Biomarker Picture

Figure 2. Global Diagnostic Exosome Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diagnostic Exosome Biomarker Market Share by Type: 2024 VS 2031

Figure 4. Membrane-bound Proteins Features

Figure 5. Soluble Proteins Features

Figure 6. Noncoding RNA Features

Figure 7. Others Features

Figure 8. Global Diagnostic Exosome Biomarker Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Diagnostic Exosome Biomarker Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Ambulatory Surgical Centers Case Studies

Figure 13. Diagnostic Exosome Biomarker Report Years Considered

Figure 14. Global Diagnostic Exosome Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Diagnostic Exosome Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Diagnostic Exosome Biomarker Market Share by Region: 2024 VS 2031

Figure 17. Global Diagnostic Exosome Biomarker Market Share by Players in 2024

Figure 18. Global Top Diagnostic Exosome Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Exosome Biomarker as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Diagnostic Exosome Biomarker Revenue in 2024

Figure 20. North America Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Diagnostic Exosome Biomarker Market Share by Country (2020-2031)

Figure 22. United States Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Diagnostic Exosome Biomarker Market Share by Country (2020-2031)

Figure 26. Germany Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Diagnostic Exosome Biomarker Market Share by Region (2020-2031)

Figure 34. China Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Diagnostic Exosome Biomarker Market Share by Country (2020-2031)

Figure 42. Mexico Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Diagnostic Exosome Biomarker Market Share by Country (2020-2031)

Figure 46. Turkey Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Diagnostic Exosome Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. 101Bio Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 50. AMS Biotechnology Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 51. BioRegenerative Sciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 52. Cell Guidance Systems Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 53. Codiak BioSciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 54. Evomic Science Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 55. ExoCyte Therapeutics Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 56. Bio-Techne Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 57. Exovita biosciences Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 58. Immune Therapy Holdings Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 59. Lonza Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 60. Norgen Biotek Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 61. ReNeuron Group Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 62. Therapeutic Solutions International Revenue Growth Rate in Diagnostic Exosome Biomarker Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Exosome Detection Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Exosome Analysis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome Therapeutics and Diagnostics Market Research Report 2024

Global Diagnostic Biomarker Market Research Report 2024

Global Exosome Technologies Market Research Report 2025

Global Exosome Therapy Technology Market Research Report 2025

Global Exosome Analyzers Market Research Report 2025

Global Exosome Therapeutics Market Research Report 2024

Global Exosome Medical Technology Market Research Report 2025

Global Exosome Service Market Research Report 2025

End to End Exosome Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome Detection and Diagnosis Market Research Report 2024

Exosome Research Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Exosome Extraction Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome Research Market Research Report 2024

Exosome Sample Oustomization Processing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2025

Global Exosome Kit Market Research Report 2024

Exosome Engineering Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions